Abstract:Background. Spinal cord injury (SCI) is one of the serious neurological diseases that occur in young people with high morbidity and disability. However, there is still a lack of effective treatments for it. Stem cell (SC) treatment of SCI has gradually become a new research hotspot over the past decades. This article is aimed at reviewing the research progress of SC therapy for SCI. Methods. Review the literature and summarize the effects, strategies, related mechanisms, safety, and clinical application of different SC types and new approaches in combination with SC in SCI treatment. Results. A large number of studies have focused on SC therapy for SCI, most of which showed good effects. The common SC types for SCI treatment include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), neural stem cells (NSCs), induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs). The modes of treatment include in vivo and in vitro induction. The pathways of transplantation consist of intravenous, transarterial, nasal, intraperitoneal, intrathecal, and intramedullary injections. Most of the SC treatments for SCI use a number of cells ranging from tens of thousands to millions. Early or late SC administration, application of immunosuppressant or not are still controversies. Potential mechanisms of SC therapy include tissue repair and replacement, neurotrophy, and regeneration and promotion of angiogenesis, antiapoptosis, and anti-inflammatory. Common safety issues include thrombosis and embolism, tumorigenicity and instability, infection, high fever, and even death. Recently, some new approaches, such as the pharmacological activation of endogenous SCs, biomaterials, 3D print, and optogenetics, have been also developed, which greatly improved the application of SC therapy for SCI. Conclusion. Most studies support the effects of SC therapy on SCI, while a few studies do not. The cell types, mechanisms, and strategies of SC therapy for SCI are very different among studies. In addition, the safety cannot be ignored, and more clinical trials are required. The application of new technology will promote SC therapy of SCI.

Cell Transplantation Therapies for Spinal Cord Injury Focusing on Bone Marrow Mesenchymal Stem Cells: Advances and Challenges

Bone Marrow Mesenchymal Stem Cells (bmscs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration

Transplantation Strategies for Spinal Cord Injury Based on Microenvironment Modulation

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Stem Cells: Current Approach and Future Prospects in Spinal Cord Injury Repair

Multipotent Mesenchymal Stem Cell-Based Therapies for Spinal Cord Injury: Current Progress and Future Prospects

Stem Cell Therapy for Spinal Cord Injury

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

A Brief Summary of Current Therapeutic Strategies for Spinal Cord Injury

Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges

Current Research Status of Bone Marrow Mesenchymal Stem Cells Transplantation for Spinal Cord Injury

Treatment of spinal cord injury with mesenchymal stem cells

Mesenchymal Stem Cells Transplantation to Treat Spinal Cord Injury: from Basic Science to Clinical Trial

Stem cell-based therapies to treat spinal cord injury: a review

Spinal cord injury: molecular mechanisms and therapeutic interventions

Current Status of Cell-Mediated Regenerative Therapies for Human Spinal Cord Injury

Thrombospondin-1 Modified Bone Marrow Mesenchymal Stem Cells (bmscs) Promote Neurite Outgrowth and Functional Recovery in Rats with Spinal Cord Injury.

Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells

Progress in Stem Cell Therapy for Spinal Cord Injury

Cell Therapeutic Strategies for Spinal Cord Injury.

Repair of the Injured Spinal Cord by Schwann Cell Transplantation